| Title |
Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
|
|---|---|
| Published in |
PLOS ONE, May 2013
|
| DOI | 10.1371/journal.pone.0063773 |
| Pubmed ID | |
| Authors |
Eduardo Ferracioli-Oda, Ahmad Qawasmi, Michael H. Bloch |
X Demographics
The data shown below were collected from the profiles of 80 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 10 | 13% |
| Netherlands | 9 | 11% |
| Australia | 6 | 8% |
| India | 4 | 5% |
| Canada | 3 | 4% |
| United States | 3 | 4% |
| United Kingdom | 2 | 3% |
| Brazil | 1 | 1% |
| Ecuador | 1 | 1% |
| Other | 5 | 6% |
| Unknown | 36 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 59 | 74% |
| Practitioners (doctors, other healthcare professionals) | 13 | 16% |
| Scientists | 6 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
| Unknown | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 544 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | <1% |
| Brazil | 2 | <1% |
| Spain | 2 | <1% |
| United States | 2 | <1% |
| India | 1 | <1% |
| Singapore | 1 | <1% |
| United Kingdom | 1 | <1% |
| Japan | 1 | <1% |
| France | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 531 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 98 | 18% |
| Student > Master | 65 | 12% |
| Researcher | 49 | 9% |
| Other | 47 | 9% |
| Student > Doctoral Student | 31 | 6% |
| Other | 98 | 18% |
| Unknown | 156 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 149 | 27% |
| Agricultural and Biological Sciences | 39 | 7% |
| Nursing and Health Professions | 27 | 5% |
| Psychology | 27 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 25 | 5% |
| Other | 101 | 19% |
| Unknown | 176 | 32% |